These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15128475)

  • 21. Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.
    Weber MA; Weir MR
    J Clin Hypertens (Greenwich); 2001; 3(4):225-35. PubMed ID: 11498653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
    Fici F; Bakir EA; Beyaz S; Makel W; Robles NR
    Prim Care Diabetes; 2018 Dec; 12(6):558-564. PubMed ID: 30327190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K
    J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roundtable discussion: management of hypertension in diabetics.
    Moser M; Sowers J; Giles T
    J Clin Hypertens (Greenwich); 2003; 5(5):345-9. PubMed ID: 14564135
    [No Abstract]   [Full Text] [Related]  

  • 27. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
    Resnick LM
    Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of diabetes mellitus associated with hypertension].
    Katayama H
    Nihon Naika Gakkai Zasshi; 1996 Apr; 85(4):514-8. PubMed ID: 8708466
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on calcium antagonists and the kidney.
    Tobe S
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    Brunström M; Eliasson M; Nilsson PM; Carlberg B
    J Hypertens; 2017 Mar; 35(3):453-462. PubMed ID: 27870655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diabetic patient with hypertension.
    Leese GP; Savage MW; Chattington PD; Vora JP
    Postgrad Med J; 1996 May; 72(847):263-8. PubMed ID: 8761497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case for combining angiotensin-converting enzyme inhibitors and calcium-channel blockers.
    Taylor AA; Sunthornyothin S
    Curr Hypertens Rep; 1999 Oct; 1(5):446-53. PubMed ID: 10981104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC
    Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.